Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study

ConclusionThis study demonstrated that in severe allergic asthma, omalizumab improves patient-reported outcomes such as patients ’ illness perception and QoL, while confirming improvement of asthma control and exacerbation rate reduction in Italian patients.

http://link.springer.com/10.1186/s40413-018-0214-3

Source: World Allergy Organization Journal - November 1, 2018 Category: Allergy & Immunology Source Type: research